the 1st public service platform of international marketing for pharmaceutical products settled in guilin pharma
after several rounds of project selection and live interview, guilin pharma was selected as the 1st public service platform of international marketing for pharmaceutical products by the department of commerce, guangxi zhuang autonomous region in late december 2013.
known as the frontier of sino-asean corporation mechanism, guangxi has extensively carried out multilateral industrial cooperation with the asean member countries over decades. the long history of guilin city as the high-tech center of guangxi for pharmaceutical industry helped the city to become one of the first national science and technology commercial innovation base, in which accumulated over 20 pharmaceutical companies specialized in manufacturing and marketing of apis, tcm and finished drugs.
since the first who prequalification of its anti-malarial drugs in 2006, guilin pharma has built the world’s most integrated artemisinin based antimalarial value chain from api production to international sales & marketing of finished drugs. the company has obtained 404 marketing approvals of its products through its global business network covering over 32 different countries and territories in africa, asia and south america.
with its success in antimalarials, guilin pharma has set up its corporation image as the symbol of safe and efficient chinese drugs internationally. we believe the successful experience will help the company to build a service platform on international marketing for pharmaceutical products for other pharmaceutical companies who are interested in the overseas market. this platform will provide a one-stop professional service of pharmaceutical products including registration, marketing, distribution and post marketing pharmacovigilance management so as to support those companies to explore the overseas market.